Progyny (PGNY) Accumulated Expenses (2018 - 2026)

Progyny (PGNY) has reported Accumulated Expenses for 9 consecutive years, with $88.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accumulated Expenses rose 10.17% year-over-year to $88.0 million in Q2 2026; TTM through Jun 2026 was $88.0 million, a 10.17% increase from a year earlier, with the FY2025 full-year figure at $78.3 million, up 6.51% from the prior year.
• Accumulated Expenses was $88.0 million for Q2 2026 at Progyny, up from $77.9 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $91.4 million in Q1 2025 and troughed at $44.0 million in Q1 2022.
• A 5-year average of $69.4 million and a median of $73.6 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses surged 39.06% in 2023 and slipped 14.77% in 2026, its largest moves.
• Over 5 years, Accumulated Expenses stood at $50.2 million in 2022, then climbed by 20.45% to $60.5 million in 2023, then rose by 21.49% to $73.5 million in 2024, then rose by 6.51% to $78.3 million in 2025, then grew by 12.4% to $88.0 million in 2026.
• The last three Accumulated Expenses figures came in at $88.0 million (Q2 2026), $77.9 million (Q1 2026), and $78.3 million (Q4 2025), per Business Quant data.